USP7 Human shRNA Plasmid Kit (Locus ID 7874)
CAT#: TF308454
USP7 - Human, 4 unique 29mer shRNA constructs in retroviral RFP vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 4,790.00
货期*
现货
规格
Cited in 1 publication. |
Product images
经常一起买 (2)
USP7 mouse monoclonal antibody, clone OTI1F12 (formerly 1F12)
CNY 1,999.00
CNY 2,700.00
Specifications
Product Data | |
Product Name | USP7 Human shRNA Plasmid Kit (Locus ID 7874) |
Locus ID | 7874 |
UniProt ID | Q93009 |
Synonyms | HAFOUS; HAUSP; TEF1 |
Vector | pRFP-C-RS |
Format | Retroviral plasmids |
Kit Components | USP7 - Human, 4 unique 29mer shRNA constructs in retroviral RFP vector(Gene ID = 7874). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pRFP-C-RS Vector, TR30015, included for free. |
RefSeq | NM_001286457, NM_001286458, NM_003470, NM_001321858, NR_135826, NM_003470.1, NM_001286458.1, NM_001286457.1, BC166690, BM661563, NM_001286458.2, NM_003470.3 |
Summary | The protein encoded by this gene belongs to the peptidase C19 family, which includes ubiquitinyl hydrolases. This protein deubiquitinates target proteins such as p53 (a tumor suppressor protein) and WASH (essential for endosomal protein recycling), and regulates their activities by counteracting the opposing ubiquitin ligase activity of proteins such as HDM2 and TRIM27, involved in the respective process. Mutations in this gene have been implicated in a neurodevelopmental disorder. [provided by RefSeq, Mar 2016] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (1)
The use of this RNAi has been cited in the following citations: |
---|
USP7 regulates ALS-associated proteotoxicity and quality control through the NEDD4L-SMAD pathway
,Zhang, T;Periz, G;Lu, YN;Wang, J;,
Proc Natl Acad Sci U S A
,PubMed ID 33106424
[USP7]
|
Documents
Product Manuals |
FAQs |
SDS |
Customer
Reviews
Loading...